Chirality-engineered nanozymes orchestrate gut microbiota-host metabolism to shield against cardiotoxicity during cancer chemotherapy via the gut-heart axis

Science Bulletin · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles